Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Advanced Thyroid Cancer Patients Who Received Target Therapy × anlotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Small Cell Lung Carcinoma 2 NSCLC 2 Thyroid Neoplasms 1 Sarcoma 1 Proteinuria 1 Platinum-resistant Ovarian Cancer (PROC) 1 Advanced Thyroid Cancer Patients Who Received Target Therapy 1

Interventions

trametinib 1 selpercatinib 1 pralsetinib 1 lenvatinib 1 larotrectinib 1 entrectinib 1 dabrafenib 1 anlotinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06195228 2025-08-14

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

Fudan University

Phase 4 Recruiting

EndocrineHead & Neck

Advanced Thyroid Cancer Patients Who Received Target Therapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡